Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-010262
Filing Date
2021-02-12
Accepted
2021-02-12 17:23:29
Documents
1
Period of Report
2021-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4082
  Complete submission text file 0001209191-21-010262.txt   5764
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MARKER THERAPEUTICS, INC. 3200 SOUTHWEST FREEWAY, SUITE 2240 HOUSTON TX 77027
Business Address
Garrett Gerald (Reporting) CIK: 0001804510 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37939 | Film No.: 21629846